Since 2000, as part of Queen Mary University of London, the William Harvey Research Institute (WHRI) and the Faculty of Medicine and Dentistry have gone from strength to strength. In the 2000 Research Assessment Exercise (REF), the Faculty was ranked overall 5th in the UK for world-leading or internationally excellent research. Over this same period, research spending increased from £18.7m to over £60m.
Our primary research focus and excellence lies in our cardiovascular, endocrine and inflammation research themes. In addition, we are home to international excellence in critical care and perioperative medicine research.
We aim to combine talents from different disciplines, such as genomics, cell biology, pharmacology, with translational bench-to-patient studies and large-scale clinical trials, all with the ambition of therapeutic innovation.
We are currently the largest pharmacological research institute in the UK University sector and one of the largest in Europe. Since 2002 we have grown from 140 people to over 530 clinicians and scientists from 45 countries.
Our mission is to: